Intellia Therapeutics NTLA Accounts Payable

Accounts Payable at other companies

Ionis PharmaceuticalsIONS

$47.7M+109%

CRISPR TherapeuticsCRSP

$13.65M+4.5%

Beam TherapeuticsBEAM

$12.29M+59.6%

Design Therapeutics, Inc.DSGN

$2.28M-28.4%

Prime MedicinePRME

$5.81M-8.9%

Iovance Biotherapeutics, Inc.IOVA

$26.21M-18.1%

FAQ

What is Intellia Therapeutics's accounts payable?

Intellia Therapeutics (NTLA) reported accounts payable of $11.71M in Q2 2026.

How has Intellia Therapeutics's accounts payable changed year-over-year?

Intellia Therapeutics's accounts payable increased by 19.5% year-over-year, from $9.8M to $11.71M.

What is the long-term trend for Intellia Therapeutics's accounts payable?

Over 5 years (2020 to 2025), Intellia Therapeutics's accounts payable has grown at a 14.1% compound annual growth rate (CAGR), from $10.46M to $20.25M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.